Wyden Statement on Mylan Settlement

Senate Finance Committee Ranking Member Ron Wyden (D-Ore.) today issued the statement below following news that Mylan NV will pay $465 million to the Department of Justice and other agencies to settle the question of whether the company had for years been vastly underpaying EpiPen rebates owed to Medicaid. “Today’s news is a first step […]

Wyden, Pallone Confirm EpiPen Makers Overcharged Medicaid for Two Decades

WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., and House Energy and Commerce Committee Ranking Member Frank Pallone, Jr. D-N.J., today issued a statement following a letter from Centers for Medicare & Medicaid Services (CMS) Acting Administrator Andy Slavitt regarding the misclassification of EpiPen as a generic drug for nearly two decades: “Today’s […]

Wyden Warns of China’s Destructive Impact on U.S. Aluminum Sector

WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., warned of the damage to U.S. workers in the aluminum sector caused by China’s trade-distorting industrial policies, in testimony he submitted to a U.S. International Trade Commission hearing today. The ITC held the hearing to evaluate competitive conditions affecting the U.S. aluminum industry, following massive […]

Senators Celebrate Planned Parenthood’s First 100 Years

Washington, D.C. – Senator Ron Wyden, D-Ore., today led 18 of his Senate colleagues in introducing a resolution to recognize the importance of Planned Parenthood’s contributions to women’s health care and reproductive rights in America over the last 100 years. Planned Parenthood will celebrate 100 years of providing care and information to millions of women […]

Wyden, Pallone Confirm EpiPen Makers Overcharged Medicaid for Two Decades

WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., and House Energy and Commerce Committee Ranking Member Frank Pallone, Jr. D-N.J., today issued a statement following a letter from Centers for Medicare & Medicaid Services (CMS) Acting Administrator Andy Slavitt regarding the misclassification of EpiPen as a generic drug for nearly two decades: “Today’s […]

Wyden Blasts EU Airbus Subsidies, Calls for Strong Enforcement of Trade Rules

WASHINGTON — Senate Finance Committee Ranking Member Ron Wyden, D-Ore., blasted the European Union for funneling billions in illegal subsidies to Airbus, as a new World Trade Organization report confirmed today. “The WTO today sent a clear message to Europe: Stop heaping billions in illegal subsidies on European companies,” said Wyden. “The massive subsidies the […]

Wyden Proposes New Middle-Income Housing Tax Credit

WASHINGTON – With the cost of housing squeezing family budgets across the country, Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today released draft legislation that would create a new tax credit to spur the development of rental homes affordable to Americans with moderate incomes. The new incentive, called the Middle-Income Housing Tax Credit (MIHTC) […]

Wyden Proposes Improvements to Medicare Benefit, Enrollment Process

Ranking Finance Democrat Introduces Sweeping Bill to Establish Out-of-Pocket Caps for Seniors, Simplify Medicare Enrollment, and Make the Program More Affordable for All   Wyden’s Legislation Also Eliminates Harmful, Senseless Two-Year Wait Period for Individuals with Disabilities to Receive Health Coverage through Medicare WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today introduced […]

Wyden Praises New Initiative To End Fishing Subsidies

WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., praised a new effort to eliminate harmful fisheries subsidies, announced today by the U.S. and 12 other nations. “Governments around the world are lavishing billions and billions in subsidies on their fishing fleets, to build more and bigger fishing boats, and use ever more extreme […]